Abstract
Introduction: The role of seizure prophylaxis in patients with isolated subdural hematoma remains uncertain. Objective: To assess the prevalence of pharmacologic prophylaxis with antiepileptic agents in patients with isolated subdural hematoma and its association with epileptic events from diagnosis to 6-month follow-up. Patients and Methods: A retrospective observational study was performed in patients with isolated subdural hematoma admitted to the ICU. The use of antiepileptic prophylaxis at discharge was evaluated and epileptic events during a period of 6 months were recorded. Results: Fifty-five patients discharged from our Service with a diagnosis of subdural hematoma over 5 years were included and analyzed. The most frequent reason for consultation was traumatic brain injury (44%) followed by new focal neurologic deficit and headache (22% each). Acute subdural hematoma was the most frequent subtype (67%), and 84% of patients had a documented recent traumatic brain injury. Eight (15%) patients received an antiepileptic agent for prophylaxis at the time of hospital discharge. During follow-up, one patient (2%) had a seizure event while receiving anti-seizure prophylaxis. Conclusion: Epileptic events following a subdural hematoma are infrequent and the role of anti-seizure prophylaxis remains uncertain.
References
Huang KT, Bi WL, Abd-El-Barr M, Yan SC, Tafel IJ, Dunn IF, et al. The Neurocritical and Neurosurgical Care of Subdural Hematomas. Neurocrit Care. 2016 Apr;24(2):294-307.
Won SY, Konczalla J, Dubinski D, Cattani A, Cuca C, Seifert V, et al. A systematic review of epileptic seizures in adults with subdural haematomas. Seizure. 2017 Feb;45:28-35.
Pruitt P, Naidech A, Van Ornam J, Borczuk P. Seizure frequency in patients with isolated subdural hematoma and preserved consciousness. Brain Inj. 2019;33(8):1059-1063.
Christensen J. Traumatic brain injury: risks of epilepsy and implications for medicolegal assessment. Epilepsia. 2012 Sep;53 Suppl 4:43-7.
Guidelines for the Management of Severe Traumatic Brain Injury. 4th Edition. Brain Trauma Foundation. Consultado noviembre 2020. Available at: https://www.braintrauma.org/uploads/03/12/Guidelines_for_Management_of_Severe_TBI_4th_Edition.pdf
Gerard C, Busl KM. Treatment of acute subdural hematoma. Curr Treat Options Neurol. 2014 Jan;16(1):275.
Battaglia F, Plas B, Melot A, Noudel R, Sol JC, Roche PH, et al. Is there any benefit from short-term perioperative antiepileptic prophylaxis in patients with chronic subdural haematoma? A retrospective controlled study. Neurochirurgie. 2015;61(5):324-328.
Ratilal BO, Pappamikail L, Costa J, Sampaio C. Anticonvulsants for preventing seizures in patients with chronic subdural haematoma. Cochrane Database Syst Rev. 2013 Jun 6;2013(6):CD004893.
Rabinstein AA, Chung SY, Rudzinski LA, Lanzino G. Seizures after evacuation of subdural hematomas: incidence, risk factors, and functional impact. J Neurosurg. 2010 Feb;112(2):455-60.
Fisher RS, Cross JH, French JA, Higurashi N, Hirsch E, Jansen FE, et al. Operational classification of seizure types by the International League Against Epilepsy: Position Paper of the ILAE Commission for Classification and Terminology. Epilepsia. 2017 Apr;58(4):522-530.
Kolias AG, Chari A, Santarius T, Hutchinson PJ. Chronic subdural haematoma: modern management and emerging therapies. Nat Rev Neurol. 2014 Oct;10(10):570-8.
Iliescu IA. Current diagnosis and treatment of chronic subdural haematomas. J Med Life. 2015 Jul-Sep;8(3):278-84.
Lavergne P, Labidi M, Brunet MC, Lessard Bonaventure P, Zetchi A, Carrondo Cottin S, et al. Efficacy of antiseizure prophylaxis in chronic subdural hematoma: a cohort study on routinely collected health data. J Neurosurg. 2019 Jan 18:1-5.
This work is licensed under a Creative Commons Attribution-ShareAlike 4.0 International License.
Copyright (c) 2023 Juan José Ruiz Martinez, Agustin Natalio Matarrese, Augusto Vilariño, Maria Celeste Caputo, Daniel Ivulich, Javier Osatnik, Barbara Hunter